Clinical Trials on Chronic Disease Obstructive Pulmonary in New Zealand
Total 5308 results
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Waikato HospitalWaikato Hospital Research FundCompletedChronic Obstructive Pulmonary DiseaseNew Zealand
-
University of Auckland, New ZealandTerminatedSmoking Cessation | Chronic Obstructive Pulmonary DiseaseNew Zealand
-
Mylan Inc.Theravance BiopharmaCompleted
-
University of OtagoHealth Research Council, New ZealandCompleted
-
Fisher and Paykel HealthcareMedical Research Institute of New Zealand; Alana HealthcareTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States, New Zealand
-
GlaxoSmithKlineCompleted
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
Mundipharma Research LimitedCompletedChronic Obstructive Pulmonary DiseaseChina, Taiwan, Korea, Republic of, New Zealand, Australia
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedStudy in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017Chronic Obstructive Pulmonary Disease (COPDUnited States, Australia, New Zealand
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
The George InstituteActive, not recruitingCardiovascular Diseases | Chronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Chile, South Africa, New Zealand
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
DeyCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
Theravance BiopharmaGlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveThailand, New Zealand, United Kingdom
-
Arrowhead PharmaceuticalsRecruitingChronic Obstructive Pulmonary Disease | AsthmaKorea, Republic of, Australia, New Zealand, Poland, Thailand, Spain
-
EmphycorpCellular Sciences, inc.Completed
-
Flinders UniversityCompletedChronic Obstructive Pulmonary Disease | DyspneaAustralia, New Zealand
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingChronic Obstructive Pulmonary Disease (COPD)United States
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
AstraZenecaQuintiles, Inc.Completed
-
Meridigen Biotech Co., Ltd.Active, not recruitingChronic Obstructive Pulmonary Disease ModerateTaiwan
-
Turino, Gerard, M.D.National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Northwell HealthTerminatedChronic Obstructive Pulmonary DiseaseUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand, United Kingdom
-
Columbia UniversityNational Institute of Environmental Health Sciences (NIEHS)CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Pulmatrix Inc.The VA Western New York Healthcare System; Buffalo Institute For Medical ResearchCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Optimum Patient CareRespiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (13645005)United States
-
Convexity Scientific IncCOPD FoundationCompletedChronic Obstructive Pulmonary Disease | COPD | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereUnited States
-
The George InstituteNational Health and Medical Research Council, AustraliaCompletedChronic Obstructive Pulmonary DiseaseAustralia
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease, COPDFrance, Poland, South Africa, Spain, United States, Canada, United Kingdom
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedEmphysema | HIV | Chronic Obstructive Pulmonary Disease (COPD)United States
-
Weill Medical College of Cornell UniversityTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States
-
Weill Medical College of Cornell UniversityTerminatedSmoking | Chronic Obstructive Pulmonary Disease | COPDUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Romania, Bulgaria, Germany, Netherlands, New Zealand
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
MediciNovaCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Beth Israel Medical CenterJohnson & JohnsonCompletedPulmonary DiseasesUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
-
University of RochesterCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
DeyCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Fu Jen Catholic UniversityCompleted
-
Weill Medical College of Cornell UniversityCompletedChronic Obstructive Pulmonary Disease (COPD)United States